Kant Drugs Private Limited - Company Profile

It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 2001.
2001 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Kant Drugs Private Limited

Kant Drugs Private Limited, a active private limited company, was established on 05 February 2001 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232UP2001PTC025855. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.15 Cr.

It upholds a compliant status. Employing 57 professional, Its leadership includes Manoj Rastogi (Director), Mehul Rastogi (Director), Anurag Das (Director). Past directors included Manoj Rastogi, Chittaranjan Das, Tribhuwan Das. It holds ₹4.24 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, 226003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UP2001PTC025855

  • Registration Number

    025855

  • Incorporation Date

    05 February 2001

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.15 Cr

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.15 Cr
  • Company Age 25 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.24 Cr
  • Revenue Growth **** 12.11%
  • Profit Growth **** 198.19%
  • Ebitda **** 28.00%
  • Net Worth 14.51%
  • Total Assets **** 18.06%
Company report

Kant Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Kant Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kant Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Manoj Rastogi Director 05 Feb 2001 Current
Mehul Rastogi Director 22 Sep 2015 Current
Anurag Das Director 01 Mar 2010 Current
Upasana Rastogi Director 15 Dec 2025 Current
Manjulata Rastogi Director 15 Dec 2025 Current
Bharati Patwari Rastogi Director 18 May 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 18 Jun 2009 Past
Pramod Abcsdd Director 20 Jun 2025 Past
Pramod Abcsdd Director 20 Jun 2025 Past
Pramod Abcsdd Director 24 Apr 2021 Past
Pramod Abcsdd Director 14 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kant Drugs.

Kant Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.11% increase. The company also saw a substantial improvement in profitability, with a 198.19% increase in profit. The company's net worth Soared by an impressive increase of 14.51%.

Kant Drugs revenue growth over time
Kant Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.11%
*******
*******
*******
*******
Revenue from Operations
*******
 14.46%
*******
*******
*******
*******
Total Assets
*******
 18.06%
*******
*******
*******
*******
Profit or Loss
*******
 198.19%
*******
*******
*******
*******
Net Worth
*******
 14.51%
*******
*******
*******
*******
EBITDA
*******
 28.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kant Drugs?

In 2021, Kant Drugs had a promoter holding of 29.00% and a public holding of 71.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹42,400,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4.24 Cr
Latest Charge Details
Date Lender Amount Status
27 Aug 2021 Hdfc Bank Limited ₹9.90 M Open
04 Jun 2016 Hdfc Bank Limited ₹3.25 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Kant Drugs?

Kant Drugs has a workforce of 57 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kant Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kant Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kant Drugs
Recent Activity within the Organization
  • Director Appointment

    The activity Upasana Rastogi was appointed as a Director was appointed as a Director on 15 Dec 2025 & has been associated with this company since 5 months 11 days . was completed.

  • Director Appointment

    Manjulata Rastogi was appointed as a Director was appointed as a Director on 15 Dec 2025 & has been associated with this company since 5 months 11 days . was recorded as a recent event.

  • Director Appointment

    Ekta Rastogi was appointed as a Director was appointed as a Director on 15 Dec 2025 & has been associated with this company since 5 months 11 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Kant Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Kant Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 3.25 Cr registered on 04 Jun 2016 with Charge ID 100035012 was modified on 13 Aug 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kant Drugs Private Limited?

The CIN of Kant Drugs Private Limited is U24232UP2001PTC025855.

Where is Kant Drugs Private Limited headquartered?

Kant Drugs Private Limited is headquartered at Bharat Ashramraja Bazar Lucknow, Uttar Pradesh, Uttar Pradesh, 226003.

When was Kant Drugs Private Limited incorporated?

Kant Drugs Private Limited was incorporated on 05 February 2001.

Who are the current directors of Kant Drugs Private Limited?

The current directors of Kant Drugs Private Limited are

What is the primary industry of Kant Drugs Private Limited?

The primary industry of Kant Drugs Private Limited is Manufacturing.

Is Kant Drugs Private Limited a listed company?

Kant Drugs Private Limited is unlisted.

What is the capital structure of Kant Drugs Private Limited?

The authorized capital of Kant Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.15 Cr.

What is the compliance status of Kant Drugs Private Limited?

The compliance status of Kant Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available